Jacqueline Benson,

Vice President, Scientific Innovation, Immunology

Jackie Benson, Ph.D. is Vice President of Immunology Scientific Innovation for Johnson & Johnson Innovation. In this role, she leads immunology-focused collaborations out of the Johnson & Johnson Innovation Center located in South San Francisco. Jackie is responsible for identifying the best external innovation opportunities and value-generating partnerships to further develop the organization’s industry-leading portfolio of Immunology investments. She works to advance the Immunology Therapeutic Area strategy while building a strong scientific reputation and network of experts in the western United States and Asia Pacific innovation communities.

Jackie joined the Janssen Pharmaceutical Companies of Johnson & Johnson in 2001 and led mechanism of action characterization of STELARA® for which she received the Johnson Medal. Concurrently, Jackie also led Janssen’s Interleukin-23 research efforts resulting in the discovery of TREMFYA®. Jackie is the lead inventor on all composition of matter patents protecting TREMFYA® worldwide. Jackie then launched a Janssen Incubator internal venture to develop novel therapeutics for systemic lupus erythematosus prior to relocating to California to join the Innovation Center.

She received her B.S. in Biology from The Ohio State University, and her Ph.D. in Immunology from the College of Medicine at The Ohio State University. She also was awarded a National Multiple Sclerosis Society postdoctoral fellowship at Stanford University School of Medicine.

Jacqueline Benson
Jacqueline Benson